Cargando…
A randomized controlled study of the efficacy of tadalafil monotherapy versus combination of tadalafil and mirabegron for the treatment of persistent overactive bladder symptoms in men presenting with lower urinary tract symptoms (CONTACT Study)
AIM: To evaluate efficacy and safety of combination of tadalafil + mirabegron for overactive bladder/benign prostatic hyperplasia (OAB/BPH). METHODS: Male patients with lower urinary tract symptoms (50 to 89 years), with remaining OAB symptoms even after administering tadalafil for more than 8 weeks...
Autores principales: | Yamanishi, Tomonori, Kaga, Kanya, Sakata, Koichi, Yokoyama, Teruhiko, Kageyama, Shinji, Fuse, Miki, Tokunaga, Shoji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027497/ https://www.ncbi.nlm.nih.gov/pubmed/31961963 http://dx.doi.org/10.1002/nau.24285 |
Ejemplares similares
-
Editorial commentary on “Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo”
por: Yamanishi, Tomonori, et al.
Publicado: (2020) -
Urodynamic efficacy of fesoterodine for the treatment of neurogenic detrusor overactivity and/or low compliance bladder
por: Kaga, Kanya, et al.
Publicado: (2020) -
Efficacy of Transcutaneous Tibial Nerve Stimulation With Silver Spike Point® Electrodes for Refractory Overactive Bladder: A Single-Arm Study
por: Kaga, Kanya, et al.
Publicado: (2023) -
Effect of co-administration of BRL-37344 and tadalafil on reduction
of overactive bladder symptoms after induction of detrusor overactivity in
mice
por: de Carvalho, Marcos Fiuza, et al.
Publicado: (2019) -
A randomized controlled trial study on effectiveness between tadalafil versus combination mirabegron and solifenacin on treatment of ureteral stent-related symptoms
por: Ciayadi, Tjia Adynata, et al.
Publicado: (2023)